J. Craig Venter shared on Twitter last week that he is retiring from Human Longevity, and returning to the J. Craig Venter Institute (JCVI) to continue his work.
George Church’s idea is to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” and himself might be one of the first volunteers to try the approach in humans.
Scientists have published the first detailed picture of the molecular structure of human telomerase, which will allow more targeted drug screens and intelligent design of new drugs.
Researchers have proposed a radical change in the way Alzheimer’s disease is defined, focusing on biological changes in the body, rather than clinical symptoms such as memory loss and cognitive decline.
New findings suggest that many senior citizens remain more cognitively and emotionally intact than commonly believed. This could perhaps provide clues as to how we can keep our minds sharper for longer.
The FDA has announced a plan to modernise its approach to evaluating new drugs for Alzheimer’s and other neurologic diseases.
New research suggests that the first modern Briton from 300 generations ago, had a darker complexion than first thought, as well as blue eyes and curly hair.